Updated 02:01 GMT, 29 Oct 2026 SPX 7,743.98 +0.28% NDX 29,813.16 +0.55% VIX 16.91 -3.48% GOLD 4,070.60 -0.10% CL 102.06 +2.16% BTC 79,850.98 -1.18%
NAS100 29,813 +0.55% S&P 7,744 +0.28% GOLD $4,071 −0.10% BTC $79,851 −1.18% VIX 16.91 −3.48% latest tape · as of 02:01 UTC
The Screen · Industrials · Aerospace & Defense

Merlin, Inc.

MRLN · Nasdaq · USD · Market cap $173M

Merlin, Inc., an aerospace and defense technology company, develops AI-powered autonomous flight software and systems for aircraft in the United States and New Zealand.

FAIL · Does not pass the screen
0.88 USD

Price as of 23 Oct 2026Daily close, not a live quoteLast reviewed 6 days ago

Screened 2026-10-23 · the tape above runs as of 02:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price0.88 USD at the 23 Oct 2026 close
  • Our ratingAvoid, current read distribution
  • Ethical screenDoes not pass
  • OptionsOpen interest leans heavily to calls (put/call 0.03)
  • Last reviewed23 Oct 2026 (6 days ago)

A summary of the dated readings below, not a live quote and not advice.

PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
17.2017.2017.20

What this means: price 0.88 against the desk's fair-value range, base estimate 17.20, over the last year.

Current read
Distribution ?
AVOID · screened 2026-10-23
  • Trend Distribution
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 0.03, read 2026-10-28
  • Ethical does not pass the values gate
Price0.88 USD
Fair value17.20
Ethical score10.0/100
RatingAVOID
Our investment reviews on this name
2026-07-02Read Distribution8.60-89.8% to today ✓First review on file: Distribution

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its distribution label.

Merlin, Inc. holds its Distribution at $0.88. The statistical read favours the sellers, held for 25 days.

As held on the ledger · 2026-10-23
PhaseDistribution · caution
Quantitative stateThe statistical read favours the sellers, held for 25 days
Price at the screen$0.88
Valuation0.00 trailing · -20.17 forward price to earnings
Values screenFAIL · score 10.0
The Workings

Five Screens, Shown in Full

Does not pass. Business activity

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean Prohibited sector: defense Fail
Debt load 0.00% Below 33% Interest-bearing debt is just 0.0% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 0.00% Below 33% Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
Receivables 0.00% Below 49% Money owed to the company is 0.0% of assets, under the 49% limit. Pass
Revenue purity 163.14% Below 5% 163.1% of revenue comes from non-compliant sources, over the 5% line. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Merlin, does not clear the screen at the business-activity stage. It operates in aerospace and defense, so the financial ratios are not the deciding factor here.

Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when MRLN's ethical verdict changes

Today MRLN does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads AVOID: it trades at roughly a 825% discount to our $17.20 fair value, 91.60% revenue growth.

17.20Conservative17.20Base case17.20Growth case 0.88Price

Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. A 824.7% margin of safety to the base estimate.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections
$26.4$16.0$5.6TODAY1y agoPROJECTIONStreet avg$25.00 +257%Street high$25.00 +257%Conservative$17.20 +145%Our fair value$17.20 +145%

Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Why it gives us pause

At -20.2x forward earnings, the price already runs ahead of the business. Our fair value sits at $17.20, below where it trades today.

The fundamentals · plain-English read
Forward P/E-20.2x
Trailing P/E0.0x
EPS, trailing-5.02
EPS, forward-0.35
Revenue growth+91.6%growing very fast
Profit margin0.0%currently unprofitable
Return on equity0.0%not currently earning a positive return on equity
Debt to equity0.00minimal debt: a conservative balance sheet
Current ratio1.10adequate liquidity, worth monitoring
52-week range5.88 - 17.00
Market cap$173M

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

MRLN trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-10-25 Distribution $1.29 +0.0% Entry 8

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (1 analysts) rates it strong buy, with a mean price target of $15.

2026-10-18 Distribution $1.29 -30.6% Entry 7

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 30.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (1 analysts) rates it strong buy, with a mean price target of $15.

2026-10-02 Distribution $1.86 -78.4% Entry 6

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 78.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (1 analysts) rates it strong buy, with a mean price target of $15.

2026-09-05 Distribution $8.60 +0.0% Entry 5

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (1 analysts) rates it strong buy, with a mean price target of $15.

2026-08-06 Distribution $8.60 +0.0% Entry 4

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (1 analysts) rates it strong buy, with a mean price target of $15.

2026-07-18 Distribution $8.60 +0.0% Entry 3

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (1 analysts) rates it strong buy, with a mean price target of $15.

2026-07-03 Distribution $8.60 +0.0% Entry 2

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.

2026-07-02 Distribution $8.60 Entry 1

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · MRLN
DateInsiderTitleTypeSharesValue
2026-03-16 GEORGE MATTHEW SPENCER Chief Executive Officer 14,890,622 ·
2025-12-09 GOLDMAN SACHS GROUP, INC. Beneficial Owner of more than 10% of a Class of Security 4,328 $46,773
2025-12-09 GOLDMAN SACHS GROUP, INC. Beneficial Owner of more than 10% of a Class of Security 4,872 $52,707

Public filings, recorded as found. The full tape lives at Insider Intelligence.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $8.66 -19.1% · $810 -19.1%
2 months $10.86 -35.5% · $646 -35.5%
3 months $8.31 -15.6% · $844 -15.6%
6 months $10.90 -35.7% · $643 -35.7%
1 year $10.30 -31.9% · $681 -31.9%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever MRLN does next, these words stay.

Merlin, Inc. · MRLN · Distribution · $0.88
Recorded 2026-10-23 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.